[
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 07:24:17",
    "publisher": "Reuters",
    "title": "Bausch + Lomb buys J&J's dry eye relief drops for $107 mln",
    "image": "https://images.financialmodelingprep.com/news/bausch-lomb-buys-jjs-dry-eye-relief-drops-for-107-20230706.jpg",
    "site": "reuters.com",
    "text": "Bausch + Lomb said on Thursday it has acquired Johnson & Johnson's eye and contact lens drops for $106.5 million in an all-cash deal to expand its portfolio of over-the-counter eye care products.",
    "url": "https://www.reuters.com/markets/deals/bausch-lomb-buys-jjs-dry-eye-relief-drops-107-million-2023-07-06/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T07:24:17-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 10:00:00",
    "publisher": "The Motley Fool",
    "title": "2 Best Biotech Stocks to Buy in July",
    "image": "https://images.financialmodelingprep.com/news/2-best-biotech-stocks-to-buy-in-july-20230706.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson and Merck both sell numerous popular medicines. Both also have encouraging pipelines that should lead to more products.",
    "url": "https://www.fool.com/investing/2023/07/06/2-best-biotech-stocks-to-buy-in-july/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T10:00:00-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 11:53:25",
    "publisher": "InvestorPlace",
    "title": "3 Super-Safe Dividend Stocks to Buy for the Rest of 2023",
    "image": "https://images.financialmodelingprep.com/news/3-supersafe-dividend-stocks-to-buy-for-the-rest-20230706.jpg",
    "site": "investorplace.com",
    "text": "In the ever-changing finance landscape, investors constantly hunt for dependable choices. Safe dividend stocks offer a strong option.",
    "url": "https://investorplace.com/2023/07/3-super-safe-dividend-stocks-to-buy-for-the-rest-of-2023/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T11:53:25-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 13:04:50",
    "publisher": "GuruFocus",
    "title": "Johnson & Johnson: A Safe and Undervalued Dividend Aristocrat",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-a-safe-and-undervalued-dividend-aristocrat-20230706.jpg",
    "site": "gurufocus.com",
    "text": "Johnson & Johnson ( JNJ , Financial) is a leading company in the pharmaceutical and consumer health care industries that was founded in 1886. One of the most recognizable brands in the world with a well-established business, it is no hot growth stock that will explode overnight, but is instead a \"boring\" business that provides essential products and has proven its ability to grow profitably in the long run.",
    "url": "https://www.gurufocus.com/news/2035138/johnson--johnson-a-safe-and-undervalued-dividend-aristocrat",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T13:04:50-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 14:48:32",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson: Supplemental BLA Of Carvykti Gives Great Growth Opportunity",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-supplemental-bla-of-carvykti-gives-great-growth-20230706.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson's Supplemental Biologics Licensing Application of CARVYKTI was filed; approval would allow company to target a much earlier Multiple Myeloma patient population. Sales of CARVYTKI have not ramped up well since launch, but efforts are being made to increase manufacturing capacity to boost revenues. DARZALEX is another drug in the pipeline which has been approved to treat patients with Multiple Myeloma.",
    "url": "https://seekingalpha.com/article/4615559-johnson-and-johnson-supplemental-bla-of-carvykti-gives-great-growth-opportunity",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T14:48:32-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-06 14:50:32",
    "publisher": "InvestorPlace",
    "title": "The 3 Best Defensive Stocks to Buy Now (and Never Sell)",
    "image": "https://images.financialmodelingprep.com/news/the-3-best-defensive-stocks-to-buy-now-and-20230706.png",
    "site": "investorplace.com",
    "text": "Investors are always looking to buy the best defensive stocks. Investing in defense stocks provides stability during uncertain times due to their reliable government contracts.",
    "url": "https://investorplace.com/2023/07/the-3-best-defensive-stocks-to-buy-now-and-never-sell/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-06T14:50:32-04:00",
    "date_et": "2023-07-06"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-07 06:00:00",
    "publisher": "The Motley Fool",
    "title": "2 Reasons to Buy Johnson & Johnson, and 1 Reason to Sell",
    "image": "https://images.financialmodelingprep.com/news/2-reasons-to-buy-johnson-johnson-and-1-reason-20230707.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson is one of today's biggest healthcare stocks by market value. The company has grown earnings and its dividend over time.",
    "url": "https://www.fool.com/investing/2023/07/07/2-reasons-to-buy-johnson-johnson-1-reason-to-sell/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-07T06:00:00-04:00",
    "date_et": "2023-07-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-07 17:00:36",
    "publisher": "Investopedia",
    "title": "Dow Jones Today: Index Falls After Soft Jobs Report",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-today-index-falls-after-soft-jobs-report-20230707.jpg",
    "site": "investopedia.com",
    "text": "Job creation came in lower than expected, and investors are still worried about higher interest rates, sending the Dow lower by about 190 points.",
    "url": "https://www.investopedia.com/dow-jones-today-index-falls-after-soft-jobs-report-7558156",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-07T17:00:36-04:00",
    "date_et": "2023-07-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-07 18:07:14",
    "publisher": "InvestorPlace",
    "title": "3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback",
    "image": "https://images.financialmodelingprep.com/news/3-beatendown-dividend-stocks-primed-for-a-profitable-comeback-20230707.jpg",
    "site": "investorplace.com",
    "text": "The great thing about strong, consistent dividend stocks? They tend to have strong, consistent businesses.",
    "url": "https://investorplace.com/2023/07/3-beaten-down-dividend-stocks-primed-for-a-profitable-comeback/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-07T18:07:14-04:00",
    "date_et": "2023-07-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-07 19:08:49",
    "publisher": "Zacks Investment Research",
    "title": "Passive Income: 3 Dividend Kings Worth a Look",
    "image": "https://images.financialmodelingprep.com/news/passive-income-3-dividend-kings-worth-a-look-20230707.jpg",
    "site": "zacks.com",
    "text": "Dividends soften the blow from drawdowns in other positions, provide more than one way to reap a return from an investment, and allow maximum returns through dividend reinvestment.",
    "url": "https://www.zacks.com/stock/news/2118297/passive-income-3-dividend-kings-worth-a-look",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-07T19:08:49-04:00",
    "date_et": "2023-07-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-08 07:20:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson Stock a Buy?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-a-buy-20230708.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson has a new look and is trying to put its litigation woes behind it. The healthcare conglomerate's dividend remains intact.",
    "url": "https://www.fool.com/investing/2023/07/08/is-johnson-johnson-stock-a-buy/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-08T07:20:00-04:00",
    "date_et": "2023-07-08"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-09 07:45:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson Stock a Buy Now?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-a-buy-now-20230709.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson's recent consumer health spinoff should help boost top-line growth. The company's remaining divisions ought to continue performing well.",
    "url": "https://www.fool.com/investing/2023/07/09/is-johnson-johnson-stock-a-buy-now/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-09T07:45:00-04:00",
    "date_et": "2023-07-09"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 05:30:00",
    "publisher": "The Motley Fool",
    "title": "Should You Buy the First Half's Worst-Performing Sector?",
    "image": "https://images.financialmodelingprep.com/news/should-you-buy-the-first-halfs-worstperforming-sector-20230710.jpg",
    "site": "fool.com",
    "text": "Healthcare stocks stumbled in the first half as investors favored higher-growth industries. Investors piled into technology and consumer discretionary stocks.",
    "url": "https://www.fool.com/investing/2023/07/10/should-you-buy-the-worst-performing-sector/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T05:30:00-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 06:14:00",
    "publisher": "Market Watch",
    "title": "Nanobiotix's stock soars after entering licensing, development deal with J&J's Janssen Pharmaceutica",
    "image": "https://images.financialmodelingprep.com/news/nanobiotixs-stock-soars-after-entering-licensing-development-deal-with-20230710.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Nanobiotix SA NBTX, +1.57% shot up 52.1% toward a 17-month high in premarket trading Monday, after the France-based biotechnology company announced a global licensing and co-development agreement with Johnson & Johnson's JNJ, -1.45% Janssen Pharmaceutica NV for its cancer treatment. Under terms of the agreement, Nanobiotix will receive up to $60 million in cash near-term, including $30 million for licensing and up to $30 to help develop for NBTXR3, which is being evaluated for treatment of head and neck cancer.",
    "url": "https://www.marketwatch.com/story/nanobiotixs-stock-soars-after-entering-licensing-development-deal-with-j-js-janssen-pharmaceutica-76f86259",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T06:14:00-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 07:46:52",
    "publisher": "InvestorPlace",
    "title": "Dividend Stocks: Here's Where to Invest $1,000 Right Now",
    "image": "https://images.financialmodelingprep.com/news/dividend-stocks-heres-where-to-invest-1000-right-now-20230710.jpg",
    "site": "investorplace.com",
    "text": "It's no wonder people are attracted to dividend stock investments. Not only are the companies typically successful, profitable enterprises, but they usually have a long history of surviving various market cycles.",
    "url": "https://investorplace.com/2023/07/dividend-stocks-heres-where-to-invest-1000-right-now/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T07:46:52-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 10:40:32",
    "publisher": "Investopedia",
    "title": "Nanobiotix ADRs Jump Over 50% After Agreement With J&J's Janssen Pharmaceutical",
    "image": "https://images.financialmodelingprep.com/news/nanobiotix-adrs-jump-over-50-after-agreement-with-jjs-20230710.jpg",
    "site": "investopedia.com",
    "text": "American depositary receipts of Nanobiotix jumped over 50% in early trading on Monday after signing an agreement with J&J's Janssen Pharmaceutical to work on co-developing a drug to treat head and neck cancer tumors.",
    "url": "https://www.investopedia.com/nanobiotix-adrs-jump-after-agreement-with-janssen-pharmaceutical-7558419",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T10:40:32-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 13:11:09",
    "publisher": "Proactive Investors",
    "title": "Nanobiotix surges on commercialization deal with J&J's Janssen for cancer therapeutic",
    "image": "https://images.financialmodelingprep.com/news/nanobiotix-surges-on-commercialization-deal-with-jjs-janssen-for-cancer-20230710.jpg",
    "site": "proactiveinvestors.com",
    "text": "French biotechnology company Nanobiotix has entered into an agreement with J&J's wholly-owned medical research and pharmaceutical arm Janssen to license, co-develop and commercialize a drug to treat head and neck cancer tumours, sending the company's shares soaring.  The agreement relates to Nanobiotix's radioenhancer NBTXR3 which is being evaluated in a Phase 3 study for the treatment of patients with locally advanced head and neck cancer and for its potential as a systemic agent in combination with anti-PD-1 immune checkpoint inhibitors for patients with metastatic cancers.",
    "url": "https://www.proactiveinvestors.com/companies/news/1020261?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T13:11:09-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 14:34:55",
    "publisher": "Proactive Investors",
    "title": "Johnson & Johnson 2Q financial results could beat even as pharma sales weigh",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-2q-financial-results-could-beat-even-as-20230710.jpg",
    "site": "proactiveinvestors.com",
    "text": "Johnson & Johnson (NYSE:JNJ) will report its second-quarter 2023 financial results on Thursday, July 20, 2023, with the company expected to generate earnings per share (EPS) for the period of $2.62, up from $2.59 a year earlier, according to Zacks Investment Research.  Its sales for the current quarter, meanwhile, are anticipated to rise 2.7% to $24.66 billion.",
    "url": "https://www.proactiveinvestors.com/companies/news/1020265?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T14:34:55-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 16:30:00",
    "publisher": "Business Wire",
    "title": "Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-ubs-medtech-tools-20230710.jpg",
    "site": "businesswire.com",
    "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the UBS MedTech, Tools and Genomics Summit on Tuesday, August 15th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Celine Martin, Company Group Chairman Cardiovascular & Specialty Solutions Group (CSS), Anthony (Tony) Long, VP, Clinical Research, Medical Affairs, Preclinical Research and Jasmina Brooks, President Biosense Webster will represent the Company in a session sche.",
    "url": "https://www.businesswire.com/news/home/20230710327307/en/Johnson-Johnson-to-Participate-in-the-UBS-MedTech-Tools-and-Genomics-Summit/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T16:30:00-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-10 18:11:50",
    "publisher": "Reuters",
    "title": "Jurors urged to impose heavy punitive damages in J&J talc trial",
    "image": "https://images.financialmodelingprep.com/news/jurors-urged-to-impose-heavy-punitive-damages-in-jj-20230710.jpg",
    "site": "reuters.com",
    "text": "Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on Monday urged a jury to order the company to pay heavy punitive damages, calling its conduct negligent and \"despicable.\"",
    "url": "https://www.reuters.com/legal/jurors-urged-impose-heavy-punitive-damages-jj-talc-trial-2023-07-10/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-10T18:11:50-04:00",
    "date_et": "2023-07-10"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-11 11:31:14",
    "publisher": "Reuters",
    "title": "U.S. FDA classifies recall of J&J's electrosurgical tools as most serious",
    "image": "https://images.financialmodelingprep.com/news/us-fda-classifies-recall-of-jjs-electrosurgical-tools-as-20230711.jpg",
    "site": "reuters.com",
    "text": "The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as the most serious, saying their use could lead to injuries or death.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-classifies-recall-jjs-electrosurgical-tools-most-serious-2023-07-11/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-11T11:31:14-04:00",
    "date_et": "2023-07-11"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-11 17:10:39",
    "publisher": "Investopedia",
    "title": "Dow Jones Today: Index Jumps 300 Points",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-today-index-jumps-300-points-20230711.jpg",
    "site": "investopedia.com",
    "text": "The Dow Jones led all indexes by moving higher by nearly 1%, as investors anticipate tomorrow's key inflation data.",
    "url": "https://www.investopedia.com/dow-jones-today-july-11-2023-7559372",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-11T17:10:39-04:00",
    "date_et": "2023-07-11"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-12 05:06:00",
    "publisher": "The Motley Fool",
    "title": "3 Dow Stocks That Are Stand-Out Buys for July (and Beyond)",
    "image": "https://images.financialmodelingprep.com/news/3-dow-stocks-that-are-standout-buys-for-july-and-20230712.jpg",
    "site": "fool.com",
    "text": "The Dow Jones Industrial Average has been one of the world's most-followed stock indexes for well over a century. The Dow Jones is composed of 30 historically profitable, time-tested businesses.",
    "url": "https://www.fool.com/investing/2023/07/12/3-dow-stocks-stand-out-buys-for-july-and-beyond/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-12T05:06:00-04:00",
    "date_et": "2023-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-12 06:59:00",
    "publisher": "The Motley Fool",
    "title": "How to Turn $10,000 Into $1,000,000 by Retirement",
    "image": "https://images.financialmodelingprep.com/news/how-to-turn-10000-into-1000000-by-retirement-20230712.jpg",
    "site": "fool.com",
    "text": "If you want your investment to be a 100-bagger, you need to have both time and above-average returns. You'll need to target growth stocks that have the potential to outperform the S&P 500.",
    "url": "https://www.fool.com/investing/2023/07/12/how-to-turn-10000-into-1000000-by-retirement/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-12T06:59:00-04:00",
    "date_et": "2023-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-12 11:03:30",
    "publisher": "Stockmarket.com",
    "title": "What Stocks To Buy Today? 3 Good Dividend Stocks In Focus",
    "image": "https://images.financialmodelingprep.com/news/what-stocks-to-buy-today-3-good-dividend-stocks-20230712.jpg",
    "site": "stockmarket.com",
    "text": "Good dividend stocks to watch in the stock market now.",
    "url": "https://stockmarket.com/featured/what-stocks-to-buy-today-3-good-dividend-stocks-in-focus-2023-07-12",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-12T11:03:30-04:00",
    "date_et": "2023-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-13 05:35:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson Stock Overvalued?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-overvalued-20230713.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson is a relatively safe stock, and it pays a decent dividend. Its valuation is higher than that of its peers, but so is its history of performance.",
    "url": "https://www.fool.com/investing/2023/07/13/is-johnson-johnson-stock-overvalued/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-13T05:35:00-04:00",
    "date_et": "2023-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-13 11:06:36",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-reports-next-week-wall-street-expects-20230713.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://www.zacks.com/stock/news/2120611/johnson-johnson-jnj-reports-next-week-wall-street-expects-earnings-growth",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-13T11:06:36-04:00",
    "date_et": "2023-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-13 13:51:19",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-letting-nonprofit-distribute-lifesaving-generic-tuberculosis-druggreatly-20230713.jpg",
    "site": "forbes.com",
    "text": "The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & Johnson's tuberculosis drug in 44 more countries.",
    "url": "https://www.forbes.com/sites/willskipworth/2023/07/13/johnson--johnson-letting-nonprofit-distribute-life-saving-generic-tuberculosis-drug-greatly-expanding-access-in-poorer-countries/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-13T13:51:19-04:00",
    "date_et": "2023-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-13 19:57:00",
    "publisher": "The Wall Street Journal",
    "title": "Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-sues-doctors-over-studies-linking-talcbased-products-20230713.jpg",
    "site": "wsj.com",
    "text": "Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products.",
    "url": "https://www.wsj.com/articles/johnson-johnson-sues-doctors-over-studies-linking-talc-based-products-and-cancer-78ffd2a7",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-13T19:57:00-04:00",
    "date_et": "2023-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-14 05:50:00",
    "publisher": "The Motley Fool",
    "title": "3 Best Buffett Stocks to Buy for the Long Haul",
    "image": "https://images.financialmodelingprep.com/news/3-best-buffett-stocks-to-buy-for-the-long-20230714.jpg",
    "site": "fool.com",
    "text": "There's a good reason why Apple is arguably Buffett's favorite stock. Amazon has tremendous growth opportunities in e-commerce and cloud services.",
    "url": "https://www.fool.com/investing/2023/07/14/3-best-buffett-stocks-to-buy-for-the-long-haul/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-14T05:50:00-04:00",
    "date_et": "2023-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-14 10:00:20",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Poised For A Muted Q2?",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-poised-for-a-muted-q2-20230714.jpg",
    "site": "forbes.com",
    "text": "We expect the company's revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion.",
    "url": "https://www.forbes.com/sites/greatspeculations/2023/07/14/johnson--johnson-poised-for-a-muted-q2/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-14T10:00:20-04:00",
    "date_et": "2023-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-14 16:35:37",
    "publisher": "Investopedia",
    "title": "Dow Jones Today: Index Up on Healthcare Earnings",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-today-index-up-on-healthcare-earnings-20230714.jpg",
    "site": "investopedia.com",
    "text": "Primarily on the strength of UnitedHealth Group's earnings, the Dow Jones gained 125 points, finishing higher every day this week",
    "url": "https://www.investopedia.com/dow-jones-today-index-up-on-healthcare-earnings-7561456",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-14T16:35:37-04:00",
    "date_et": "2023-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-14 19:10:45",
    "publisher": "Seeking Alpha",
    "title": "COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down",
    "image": "https://images.financialmodelingprep.com/news/compass-the-landscape-is-changing-quickly-risk-is-up-20230714.jpg",
    "site": "seekingalpha.com",
    "text": "COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down",
    "url": "https://seekingalpha.com/article/4617221-compass-landscape-changing-quickly-risk-up-potential-down",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-14T19:10:45-04:00",
    "date_et": "2023-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-15 05:30:00",
    "publisher": "The Motley Fool",
    "title": "2 Warren Buffett Stocks to Buy Hand Over Fist",
    "image": "https://images.financialmodelingprep.com/news/2-warren-buffett-stocks-to-buy-hand-over-fist-20230715.jpg",
    "site": "fool.com",
    "text": "Amazon shares have climbed this year as cost-cutting efforts started to bear fruit. Johnson & Johnson is spinning off its slowest-growth business -- a move that should spur overall revenue growth.",
    "url": "https://www.fool.com/investing/2023/07/15/2-warren-buffett-stocks-to-buy-hand-over-fist/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-15T05:30:00-04:00",
    "date_et": "2023-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-15 13:35:00",
    "publisher": "Business Wire",
    "title": "J&J-Stop TB Partnership Deal a Positive Step but More Is Needed, says AHF",
    "image": "https://images.financialmodelingprep.com/news/jjstop-tb-partnership-deal-a-positive-step-but-more-20230715.jpg",
    "site": "businesswire.com",
    "text": "LOS ANGELES--(BUSINESS WIRE)-- #COVID19--With Johnson and Johnson (J&J) recently granting permission to Stop TB Partnership to distribute its generic TB drug bedaquiline (SIRTURO) to the majority of low- and middle-income countries, AIDS Healthcare Foundation (AHF) applauds Stop TB Partnership and the TB community overall for their strong leadership and advocacy in inking this vital agreement. While the deal is a positive step, AHF agrees with advocates, including Médecins Sans Frontières and others,.",
    "url": "https://www.businesswire.com/news/home/20230715036104/en/JJ-Stop-TB-Partnership-Deal-a-Positive-Step-but-More-Is-Needed-says-AHF/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-15T13:35:00-04:00",
    "date_et": "2023-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-16 06:15:00",
    "publisher": "The Motley Fool",
    "title": "3 Dividend Growth Stocks to Buy and Hold",
    "image": "https://images.financialmodelingprep.com/news/3-dividend-growth-stocks-to-buy-and-hold-20230716.jpg",
    "site": "fool.com",
    "text": "AbbVie has grown its dividend by an impressive 270% since 2013. Johnson & Johnson is a Dividend King with an above-average yield.",
    "url": "https://www.fool.com/investing/2023/07/16/3-dividend-growth-stocks-to-buy-and-hold/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-16T06:15:00-04:00",
    "date_et": "2023-07-16"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-17 05:30:00",
    "publisher": "The Motley Fool",
    "title": "2 Monster Stocks to Buy Without Any Hesitation",
    "image": "https://images.financialmodelingprep.com/news/2-monster-stocks-to-buy-without-any-hesitation-20230717.jpg",
    "site": null,
    "text": "These two companies -- giants in the worlds of biotech and pharma -- have a great earnings track record. And they both may be about to enter a new era of growth.",
    "url": "https://www.fool.com/investing/2023/07/17/2-monster-stocks-to-buy-without-any-hesitation/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-17T05:30:00-04:00",
    "date_et": "2023-07-17"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-17 21:03:04",
    "publisher": "Zacks Investment Research",
    "title": "3 Quarterly Reports Investors Can't Ignore This Week",
    "image": "https://images.financialmodelingprep.com/news/3-quarterly-reports-investors-cant-ignore-this-week-20230717.jpg",
    "site": "zacks.com",
    "text": "Earnings season is always an exciting time to be an investor, with companies finally pulling the curtain back and unveiling what's transpired behind closed doors.",
    "url": "https://www.zacks.com/stock/news/2122473/3-quarterly-reports-investors-can-t-ignore-this-week",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-17T21:03:04-04:00",
    "date_et": "2023-07-17"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 11:59:35",
    "publisher": "Reuters",
    "title": "J&J sues US govt to halt Medicare drug price negotiation plans",
    "image": "https://images.financialmodelingprep.com/news/jj-sues-us-govt-to-halt-medicare-drug-price-20230718.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block enforcement of a program that gives Medicare the power to negotiate drug prices.",
    "url": "https://www.reuters.com/legal/jj-sues-us-govt-halt-medicare-drug-price-negotiation-plans-2023-07-18/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T11:59:35-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 13:07:47",
    "publisher": "CNBC",
    "title": "Johnson & Johnson sues Biden administration over Medicare drug price negotiations",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-sues-biden-administration-over-medicare-drug-price-20230718.jpeg",
    "site": "cnbc.com",
    "text": "Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.",
    "url": "https://www.cnbc.com/2023/07/18/jj-sues-biden-administration-over-medicare-drug-negotiations.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T13:07:47-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 13:35:47",
    "publisher": "Zacks Investment Research",
    "title": "J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector",
    "image": "https://images.financialmodelingprep.com/news/jj-jnj-to-begin-q2-earnings-season-for-drug-biotech-20230718.jpg",
    "site": "zacks.com",
    "text": "Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment, recovery in surgical procedures and new product launches are likely to have pushed sales growth.",
    "url": "https://www.zacks.com/stock/news/2123096/j-j-jnj-to-begin-q2-earnings-season-for-drug-biotech-sector",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T13:35:47-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 15:08:38",
    "publisher": "ETF Trends",
    "title": "Play Earnings News in Fidelity's Low-Fee ETF Suite",
    "image": "https://images.financialmodelingprep.com/news/play-earnings-news-in-fidelitys-lowfee-etf-suite-20230718.jpg",
    "site": "etftrends.com",
    "text": "Earnings news is back on the menu for investors this week, and with that news comes ETFs to play those results. Whether it's Johnson & Johnson (JNJ), or Netflix (NFLX), ETFs can help.",
    "url": "https://www.etftrends.com/play-earnings-news-fidelitys-low-fee-etf-suite/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T15:08:38-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 15:43:47",
    "publisher": "Proactive Investors",
    "title": "Johnson & Johnson sues Biden administration to stop Medicare from negotiating its own drug prices",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-sues-biden-administration-to-stop-medicare-from-20230718.jpg",
    "site": "proactiveinvestors.com",
    "text": "Johnson & Johnson (NYSE:JNJ) is suing the US government in a bid to block a program that would give the government health insurance program Medicare the ability to negotiate for lower drug prices.  J&J is the latest major drugmaker to sue the Biden administration, joining Merck and Bristol Myers Squibb.",
    "url": "https://www.proactiveinvestors.com/companies/news/1021051?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T15:43:47-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 16:40:00",
    "publisher": "Market Watch",
    "title": "Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-joins-merck-others-in-fighting-medicare-drugprice-20230718.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson JNJ, -0.01% has joined companies such as Merck & Co. Inc. MRK, +0.36%, Bristol Myers Squibb Co. BMY, +0.24% and other entities in suing the federal government over Medicare's drug-price negotiation program. Merck was first with its suit in June, alleging that the plan is a scheme to allow Medicare to obtain prescription drugs without paying fair market value, a contention the Biden administration has decried.",
    "url": "https://www.marketwatch.com/story/johnson-johnson-joins-merck-others-in-fighting-medicare-drug-price-program-9254b71f",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T16:40:00-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 19:21:19",
    "publisher": "Reuters",
    "title": "J&J must pay $18.8 mln to California cancer patient in baby powder suit",
    "image": "https://images.financialmodelingprep.com/news/jj-must-pay-188-mln-to-california-cancer-patient-20230718.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in U.S. bankruptcy court.",
    "url": "https://www.reuters.com/legal/jj-must-pay-188-mln-california-cancer-patient-baby-powder-suit-2023-07-18/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T19:21:19-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-18 22:31:14",
    "publisher": "CNN",
    "title": "Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-must-pay-188-million-to-california-cancer-20230718.jpg",
    "site": "cnn.com",
    "text": "Johnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle thousands of similar cases over its talc-based products in US bankruptcy court.",
    "url": "https://www.cnn.com/2023/07/18/business/johnson-and-johnson-baby-powder-suit/index.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-18T22:31:14-04:00",
    "date_et": "2023-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-19 13:58:01",
    "publisher": "The Guardian",
    "title": "Johnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuit",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-must-pay-188m-to-cancer-patient-in-20230719.jpg",
    "site": "theguardian.com",
    "text": "Jury rules in favor of California man who says he developed a deadly cancer from heavy exposure to talc powder since childhood",
    "url": "https://www.theguardian.com/business/2023/jul/19/johnson-johnson-cancer-patient-lawsuit",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-19T13:58:01-04:00",
    "date_et": "2023-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-19 22:56:03",
    "publisher": "Seeking Alpha",
    "title": "Our Dividend Growth Portfolio Continues To Outpace The S&P 500",
    "image": "https://images.financialmodelingprep.com/news/our-dividend-growth-portfolio-continues-to-outpace-the-sp-20230719.jpg",
    "site": "seekingalpha.com",
    "text": "In 2015, I purchased 15 of the largest cap U.S. dividend achievers, which have continued to outpace the S&P 500. The portfolio was designed to provide greater protection during recessions and severe bear markets, and began to pull away from the S&P 500 after the world changed in 2020. The portfolio is 55% U.S. stocks and 45% Canadian stocks, with modest allocations to bonds, cash, gold and bitcoin, and a few thematic plays in the electric vehicle and battery space.",
    "url": "https://seekingalpha.com/article/4618258-our-dividend-growth-portfolio-continues-to-outpace-the-s-and-p-500",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-19T22:56:03-04:00",
    "date_et": "2023-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 06:20:00",
    "publisher": "Business Wire",
    "title": "Johnson & Johnson Reports Q2 2023 Results",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q2-2023-results-20230720.jpg",
    "site": "businesswire.com",
    "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter 2023. “Our robust performance in the second quarter and first half of 2023 is a testament to the hard work and commitment of our colleagues around the world,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer. “We are entering the back half of the year from a position of strength with numerous catalysts, including becoming a two-sector company focused on Pharmac.",
    "url": "https://www.businesswire.com/news/home/20230720974196/en/Johnson-Johnson-Reports-Q2-2023-Results/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T06:20:00-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 06:22:23",
    "publisher": "Reuters",
    "title": "J&J raises annual profit forecast on medical devices, cancer drugs strength",
    "image": "https://images.financialmodelingprep.com/news/jj-raises-annual-profit-forecast-on-medical-devices-cancer-20230720.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its cancer drugs such as Darzalex.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-raises-annual-profit-forecast-medical-devices-cancer-drugs-strength-2023-07-20/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T06:22:23-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 06:24:49",
    "publisher": "CNBC",
    "title": "Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-beats-on-earnings-hikes-fullyear-guidance-as-20230720.jpeg",
    "site": "cnbc.com",
    "text": "The results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.",
    "url": "https://www.cnbc.com/2023/07/20/johnson-johnson-jnj-q2-earnings-report-2023.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T06:24:49-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 06:25:00",
    "publisher": "Business Wire",
    "title": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2023-20230720.jpg",
    "site": "businesswire.com",
    "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2023 of $1.19 per share on the company's common stock. The dividend is payable on September 7, 2023 to shareholders of record at the close of business on August 28, 2023. The ex-dividend date is August 25, 2023. About Johnson & Johnson At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communi.",
    "url": "https://www.businesswire.com/news/home/20230720929139/en/Johnson-Johnson-Announces-Quarterly-Dividend-for-Third-Quarter-2023/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T06:25:00-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 06:34:00",
    "publisher": "Market Watch",
    "title": "Johnson & Johnson's stock up 2.4% premarket after earnings top estimates and company raises guidance",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-stock-up-24-premarket-after-earnings-top-20230720.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson's stock JNJ, -0.20% rose 2.4% in premarket trade Thursday, after the health care company posted better-than-expected second-quarter earnings and raised its guidance. The company posted net income of $5.144 billion, or $1.96 a share, for the quarter, up from $4.814 billion, or $1.80 a share, in the year-earlier period.",
    "url": "https://www.marketwatch.com/story/johnson-johnsons-stock-up-2-4-premarket-after-earnings-top-estimates-and-company-raises-guidance-7311b793",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T06:34:00-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 07:30:38",
    "publisher": "Investopedia",
    "title": "5 Things to Know Before Markets Open",
    "image": "https://images.financialmodelingprep.com/news/5-things-to-know-before-markets-open-20230720.jpg",
    "site": "investopedia.com",
    "text": "Tesla shares fell after reporting revenue that beat expectations but lower profit margins thanks to price cuts, and Netflix shares tumbled after it missed on revenue projections despite strong subscriber growth. Here's what investors need to know today.",
    "url": "https://www.investopedia.com/5-things-to-know-before-markets-open-july-20-2023-7563344",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T07:30:38-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 07:32:27",
    "publisher": "CNBC",
    "title": "Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO",
    "image": "https://images.financialmodelingprep.com/news/kenvue-earnings-top-estimates-in-jj-spinoffs-first-quarterly-20230720.jpeg",
    "site": "cnbc.com",
    "text": "J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff's business for the time being.",
    "url": "https://www.cnbc.com/2023/07/20/kenvue-kvue-q2-earnings-report-2023.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T07:32:27-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 07:41:08",
    "publisher": "Proactive Investors",
    "title": "Johnson & Johnson reports 2Q earnings beat and raises guidance",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-2q-earnings-beat-and-raises-guidance-20230720.jpg",
    "site": "proactiveinvestors.com",
    "text": "Johnson & Johnson (NYSE:JNJ) has delivered second-quarter earnings that beat expectations and has raised its full-year guidance, sending its shares higher in Thursday pre-marketing trading.  The company reported a 6.3% rise in sales to $25.5 billion for the three months to June 30, 2023.",
    "url": "https://www.proactiveinvestors.com/companies/news/1021252?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T07:41:08-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 09:09:48",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Tops Q2 Earnings and Revenue Estimates",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-tops-q2-earnings-and-revenue-estimates-20230720.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.61 per share. This compares to earnings of $2.59 per share a year ago.",
    "url": "https://www.zacks.com/stock/news/2124299/johnson-johnson-jnj-tops-q2-earnings-and-revenue-estimates",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T09:09:48-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 10:39:43",
    "publisher": "Zacks Investment Research",
    "title": "Here's What Key Metrics Tell Us About Johnson & Johnson (JNJ) Q2 Earnings",
    "image": "https://images.financialmodelingprep.com/news/heres-what-key-metrics-tell-us-about-johnson-johnson-20230720.jpg",
    "site": "zacks.com",
    "text": "Although the revenue and EPS for Johnson & Johnson (JNJ) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.",
    "url": "https://www.zacks.com/stock/news/2124528/here-s-what-key-metrics-tell-us-about-johnson-johnson-jnj-q2-earnings",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T10:39:43-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:07:50",
    "publisher": "The Motley Fool",
    "title": "2 Ultra-Safe Dividend Stocks Retirees May Want to Consider Buying",
    "image": "https://images.financialmodelingprep.com/news/2-ultrasafe-dividend-stocks-retirees-may-want-to-consider-20230720.jpg",
    "site": "fool.com",
    "text": "Dividend stocks often provide an important source of income for retirees. Target and Johnson & Johnson are two top-shelf dividend stocks suitable for risk-averse investors.",
    "url": "https://www.fool.com/investing/2023/07/20/2-ultra-safe-dividend-stocks-retirees-may-want-to/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:07:50-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:08:47",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Stock Is Rising Today",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-stock-is-rising-today-20230720.jpg",
    "site": "fool.com",
    "text": "The healthcare giant posted better-than-expected 2023 Q2 financial results today.",
    "url": "https://www.fool.com/investing/2023/07/20/why-johnson-johnson-stock-is-rising-today/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:08:47-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:17:29",
    "publisher": "Invezz",
    "title": "J&J raises full-year outlook: ‘we're in a very strong position'",
    "image": "https://images.financialmodelingprep.com/news/jj-raises-fullyear-outlook-were-in-a-very-strong-20230720.jpg",
    "site": "invezz.com",
    "text": "Johnson & Johnson (NYSE: JNJ) opened 5.0% up on Thursday after reporting market-beating results for its fiscal second quarter. J&J stock up on strong outlook Investors are cheering the raised guidance as well.",
    "url": "https://invezz.com/news/2023/07/20/jj-cfo-on-strong-q2-and-raised-full-year-outlook/?utm_source=snapi",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:17:29-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:26:49",
    "publisher": "Proactive Investors",
    "title": "Kenvue debuts from Johnson and Johnson with strong 2Q results",
    "image": "https://images.financialmodelingprep.com/news/kenvue-debuts-from-johnson-and-johnson-with-strong-2q-20230720.jpg",
    "site": "proactiveinvestors.com",
    "text": "Kenvue Inc has reported a strong set of maiden results following its spin-out from Johnson & Johnson (NYSE:JNJ) earlier this year.  The consumer health company, whose brands include Aveeno, BAND-AID, Johnson's, Listerine, Neutrogena and Tylenol, reported a 5.4% increase in net sales for the three months to June 30, 2023.",
    "url": "https://www.proactiveinvestors.com/companies/news/1021287?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:26:49-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:26:53",
    "publisher": "Zacks Investment Research",
    "title": "Q2 Beats for J&J, American; Jobless Claims, Philly Fed Lower",
    "image": "https://images.financialmodelingprep.com/news/q2-beats-for-jj-american-jobless-claims-philly-fed-lower-20230720.jpg",
    "site": "zacks.com",
    "text": "Both J&J and American Airlines put up solid beats on top and bottom lines, while the labor market remains buoyant.",
    "url": "https://www.zacks.com/stock/news/2124566/q2-beats-for-j-j-american-jobless-claims-philly-fed-lower",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:26:53-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 11:36:04",
    "publisher": "MarketBeat",
    "title": "Johnson & Johnson's Inflection Point: What it Means for Investors",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-inflection-point-what-it-means-for-investors-20230720.jpg",
    "site": "marketbeat.com",
    "text": "After three years of waiting, Johnson & Johnson NYSE: JNJ shares have returned to trend, a monumental event for the market which presents a potential buying opportunity for income investors.",
    "url": "https://www.marketbeat.com/originals/johnson-and-johnson-is-at-an-inflection-point/?utm_source=snapi",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T11:36:04-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 12:06:00",
    "publisher": "The Wall Street Journal",
    "title": "Johnson & Johnson Rips Off the Kenvue Band-Aid",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-rips-off-the-kenvue-bandaid-20230720.jpg",
    "site": "wsj.com",
    "text": "A surprisingly early distribution and a stretched valuation hit J&J's consumer health arm hard.",
    "url": "https://www.wsj.com/articles/johnson-johnson-rips-off-the-kenvue-band-aid-61a8358d",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T12:06:00-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 12:20:49",
    "publisher": "Investopedia",
    "title": "J&J Beats Estimates and Boosts Outlook as Medtech Product Demand Grows",
    "image": "https://images.financialmodelingprep.com/news/jj-beats-estimates-and-boosts-outlook-as-medtech-product-20230720.jpg",
    "site": "investopedia.com",
    "text": "Shares of Johnson & Johnson advanced as the pharmaceutical and medical products firm posted better-than-expected results and raised its guidance on higher demand for its medtech products.",
    "url": "https://www.investopedia.com/jnj-beats-estimates-and-boosts-outlook-as-medtech-product-demand-grows-7563378",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T12:20:49-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 12:26:06",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson (JNJ) Q2 2023 Earnings Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-q2-2023-earnings-call-transcript-20230720.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson (NYSE:JNJ ) Q2 2023 Earnings Conference Call July 20, 2023 8:30 AM ET Company Participants Jessica Moore - Vice President of Investor Relations Joaquin Duato - Chairman of the Board and Chief Executive Officer Joe Wolk - Executive Vice President, Chief Financial Officer Erik Haas - Worldwide Vice President of Litigation Conference Call Participants Larry Biegelsen - Wells Fargo Vamil Divan - Guggenheim Securities Joanne Wuensch - Citibank Chris Schott - JPMorgan Trung Huynh - Credit Suisse Terence Flynn - Morgan Stanley Danielle Antalffy - UBS Louise Chen - Cantor Fitzgerald Operator Good morning, and welcome to Johnson & Johnson's Second Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference.",
    "url": "https://seekingalpha.com/article/4618462-johnson-and-johnson-jnj-q2-2023-earnings-call-transcript",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T12:26:06-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 12:31:19",
    "publisher": "Stockmarket.com",
    "title": "What Stocks To Buy Today? 2 Dow Jones Industrial Average Stocks To Watch",
    "image": "https://images.financialmodelingprep.com/news/what-stocks-to-buy-today-2-dow-jones-industrial-20230720.jpg",
    "site": "stockmarket.com",
    "text": "Dow Jones Industrial Average stocks to watch in the stock market right now.",
    "url": "https://stockmarket.com/featured/what-stocks-to-buy-today-2-dow-jones-industrial-average-stocks-to-watch-2023-07-20",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T12:31:19-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 13:05:40",
    "publisher": "Investopedia",
    "title": "Markets Mixed at Midday on Weaker Earnings Reports",
    "image": "https://images.financialmodelingprep.com/news/markets-mixed-at-midday-on-weaker-earnings-reports-20230720.jpg",
    "site": "investopedia.com",
    "text": "U.S. equites were mixed at midday on July 20, 2023 as weak earnings news, especially in the tech sector, held back gains.",
    "url": "https://www.investopedia.com/markets-mixed-at-midday-on-weaker-earnings-reports-7563470",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T13:05:40-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 13:39:17",
    "publisher": "Zacks Investment Research",
    "title": "J&J (JNJ) Q2 Earnings & Sales Top, '23 View Upped, Stock Jumps",
    "image": "https://images.financialmodelingprep.com/news/jj-jnj-q2-earnings-sales-top-23-view-upped-20230720.jpg",
    "site": "zacks.com",
    "text": "J&J (JNJ) beats estimates for second-quarter earnings and sales. It raises full-year sales and earnings guidance.",
    "url": "https://www.zacks.com/stock/news/2124887/j-j-jnj-q2-earnings-sales-top-23-view-upped-stock-jumps",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T13:39:17-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 14:33:00",
    "publisher": "The Motley Fool",
    "title": "These 2 Stocks Just Sent the Dow Jones Soaring",
    "image": "https://images.financialmodelingprep.com/news/these-2-stocks-just-sent-the-dow-jones-soaring-20230720.jpg",
    "site": "fool.com",
    "text": "The Dow outpaced other market indexes on Thursday afternoon. Johnson & Johnson announced solid growth in the second quarter of 2023.",
    "url": "https://www.fool.com/investing/2023/07/20/these-2-stocks-just-sent-the-dow-jones-soaring/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T14:33:00-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 14:36:15",
    "publisher": "InvestorPlace",
    "title": "Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-giving-up-on-kenvue-kvue-stock-20230720.png",
    "site": "investorplace.com",
    "text": "One of the more interesting moves in today's market comes from recent spinoff Kenvue (NYSE: KVUE ). Currently, shares of KVUE stock are down around 3% in today's session, as the company reported earnings that beat Wall Street estimates by a rather wide margin.",
    "url": "https://investorplace.com/2023/07/is-johnson-johnson-giving-up-on-kenvue-kvue-stock/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T14:36:15-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 15:44:08",
    "publisher": "CNBC",
    "title": "Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-investors-can-soon-swap-their-shares-for-20230720.jpeg",
    "site": "cnbc.com",
    "text": "J&J owns nearly 90% of Kenvue shares and plans to reduce its stake in the company through an exchange offer that could launch \"as early as the coming days.\"",
    "url": "https://www.cnbc.com/2023/07/20/jj-investors-can-soon-swap-shares-for-kenvue-stock.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T15:44:08-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-20 16:18:18",
    "publisher": "InvestorPlace",
    "title": "3 of the Best Dividend Stocks to Buy for Passive Income Growth",
    "image": "https://images.financialmodelingprep.com/news/3-of-the-best-dividend-stocks-to-buy-for-20230720.jpg",
    "site": "investorplace.com",
    "text": "Investors seeking income from dividend stocks should carefully consider the yield offered. While the average yield in the S&P 500 is 1.56%, some stocks offer double or even triple that amount.",
    "url": "https://investorplace.com/2023/07/3-of-the-best-dividend-stocks-to-buy-for-passive-income-growth/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-20T16:18:18-04:00",
    "date_et": "2023-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-21 09:12:07",
    "publisher": "Zacks Investment Research",
    "title": "Stocks in Focus on Dow Jones ETF's First 9-Day Run Since 2017",
    "image": "https://images.financialmodelingprep.com/news/stocks-in-focus-on-dow-jones-etfs-first-9day-20230721.jpg",
    "site": "zacks.com",
    "text": "Since last week, the Dow Jones index has been performing very well. The index jumped more than 150 points yesterday to log its first nine-day rally since 2017, per a CNBC article.",
    "url": "https://www.zacks.com/stock/news/2125200/stocks-in-focus-on-dow-jones-etf-s-first-9-day-run-since-2017",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-21T09:12:07-04:00",
    "date_et": "2023-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-21 11:27:16",
    "publisher": "Zacks Investment Research",
    "title": "5 ETFs to Buy on JNJ's Q2 Earnings Strength",
    "image": "https://images.financialmodelingprep.com/news/5-etfs-to-buy-on-jnjs-q2-earnings-strength-20230721.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) continued with its long streak of earnings beat. It topped the revenue estimate as well as lifted the full-year outlook.",
    "url": "https://www.zacks.com/stock/news/2125412/5-etfs-to-buy-on-jnj-s-q2-earnings-strength",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-21T11:27:16-04:00",
    "date_et": "2023-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-21 12:12:04",
    "publisher": "Zacks Investment Research",
    "title": "ETFs to Tap Dow Jones' Longest Winning Streak Since 2017",
    "image": "https://images.financialmodelingprep.com/news/etfs-to-tap-dow-jones-longest-winning-streak-since-20230721.jpg",
    "site": "zacks.com",
    "text": "Dow Jones climbed for nine consecutive sessions, marking the longest winning streak since Sep 20, 2017.",
    "url": "https://www.zacks.com/stock/news/2125466/etfs-to-tap-dow-jones-longest-winning-streak-since-2017",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-21T12:12:04-04:00",
    "date_et": "2023-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-21 15:03:55",
    "publisher": "Investors Business Daily",
    "title": "11 Stocks Drive The Dow's Amazing 10-Straight Day Rally",
    "image": "https://images.financialmodelingprep.com/news/11-stocks-drive-the-dows-amazing-10straight-day-rally-20230721.jpg",
    "site": "investors.com",
    "text": "The Dow's 10-straight day rally keeps making history — it hasn't done this since at least 2017. And investors can thank a select group.",
    "url": "https://www.investors.com/etfs-and-funds/sectors/dow-jones-stocks-drive-the-dows-amazing-straight-day-rally/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-21T15:03:55-04:00",
    "date_et": "2023-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 06:18:00",
    "publisher": "Business Wire",
    "title": "Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-launches-exchange-offer-for-separation-of-kenvue-20230724.jpg",
    "site": "businesswire.com",
    "text": "NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced its intention to split-off at least 80.1% of the shares of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) through an exchange offer. Kenvue, formerly Johnson & Johnson's Consumer Health business, completed its initial public offering (“IPO”) in May 2023. Through the planned exchange offer, Johnson & Johnson shareholders can exchange all, some or none of their shares of Johnson & Johnson common stock for sha.",
    "url": "https://www.businesswire.com/news/home/20230723805654/en/Johnson-Johnson-Launches-Exchange-Offer-for-Separation-of-Kenvue-Inc./",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T06:18:00-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 06:22:00",
    "publisher": "Business Wire",
    "title": "Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement",
    "image": "https://images.financialmodelingprep.com/news/kenvue-to-file-form-s4-registration-statement-in-connection-20230724.jpg",
    "site": "businesswire.com",
    "text": "SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) announced intent to file a Form S-4 Registration Statement today with the Securities and Exchange Commission.",
    "url": "https://www.businesswire.com/news/home/20230723704684/en/Kenvue-To-File-Form-S-4-Registration-Statement-in-Connection-with-Johnson-Johnson-Exchange-Offer-Announcement/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T06:22:00-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 06:29:00",
    "publisher": "Market Watch",
    "title": "Johnson & Johnson to spin off at least 80.1% of Kenvue shares in an exchange offer",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-spin-off-at-least-801-of-20230724.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson JNJ, +1.07% said Monday it is planning to spin off at least 80.1% of its shares of Kenvue Inc. KVUE, -2.04% through an exchange offer. The consumer goods and healthcare giant announced its intention to launch an exchange offer for the separation of Kenvue, its consumer health business which went public in May, when it reported earnings last week.",
    "url": "https://www.marketwatch.com/story/johnson-johnson-to-spin-off-at-least-80-1-of-kenvue-shares-in-an-exchange-offer-8f92950a",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T06:29:00-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 06:38:22",
    "publisher": "Reuters",
    "title": "J&J begins share exchange offer for consumer health spin-off Kenvue",
    "image": "https://images.financialmodelingprep.com/news/jj-begins-share-exchange-offer-for-consumer-health-spinoff-20230724.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson said on Monday it had launched an exchange offer for its investors to exchange J&J's shares with those of its consumer health unit Kenvue.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-begins-share-exchange-offer-consumer-health-spin-off-kenvue-2023-07-24/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T06:38:22-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 08:01:42",
    "publisher": "MarketBeat",
    "title": "3 Consumer Discretionary Stocks That Still Have Pricing Power",
    "image": "https://images.financialmodelingprep.com/news/3-consumer-discretionary-stocks-that-still-have-pricing-power-20230724.jpg",
    "site": "marketbeat.com",
    "text": "What's one of the best predictors of stock price performance? If you said earnings growth, you're right.",
    "url": "https://www.marketbeat.com/originals/3-consumer-discretionary-stocks-that-still-have-pricing-power/?utm_source=snapi",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T08:01:42-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 08:33:00",
    "publisher": "Proactive Investors",
    "title": "Johnson & Johnson talcum powder settlement among largest ever",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-talcum-powder-settlement-among-largest-ever-20230724.jpg",
    "site": "proactiveinvestors.co.uk",
    "text": "Johnson & Johnson (NYSE:JNJ)'s bid to settle thousands of lawsuits that claimed the company's talcum powder caused cancer is among the largest ever when adjusted for inflation. Having agreed to pay around £6.8bn (US$8.9bn) to settle the cases in April, J&J's proposed pay-out marks the largest since the early 2000s and the eighth highest of all time, according to Arizona-based law firm High Rise Financial.",
    "url": "https://www.proactiveinvestors.co.uk/companies/news/1021499?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T08:33:00-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 08:36:48",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Bankruptcy Talk: Q2 Earnings Soar, But Litigation Looms On Horizon",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-bankruptcy-talk-q2-earnings-soar-but-litigation-20230724.jpg",
    "site": "forbes.com",
    "text": "The company has proposed a $8.9 billion settlement to end tens of thousands of cases and stop new ones from coming through",
    "url": "https://www.forbes.com/sites/qai/2023/07/24/johnson--johnson-bankruptcy-talk-q2-earnings-soar-but-litigation-looms-on-horizon/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T08:36:48-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 08:54:15",
    "publisher": "Proactive Investors",
    "title": "Johnson & Johnson launches share exchange offering for Kenvue",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-launches-share-exchange-offering-for-kenvue-20230724.jpg",
    "site": "proactiveinvestors.com",
    "text": "Johnson & Johnson (NYSE:JNJ) (J&J) has launched a share exchange offer for its former consumer health business Kenvue which completed its initial public offering in May. Shareholders of J&J can opt to exchange some or all of their shares for Kenvue stock at a 7% discount, subject to certain conditions, the company announced on Monday.",
    "url": "https://www.proactiveinvestors.com/companies/news/1021504?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T08:54:15-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 09:03:42",
    "publisher": "CNBC",
    "title": "Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-reduce-its-kenvue-stake-by-at-20230724.jpeg",
    "site": "cnbc.com",
    "text": "J&J said it received a waiver that dismisses the share lockup period associated with Kenvue's initial public offering in May.",
    "url": "https://www.cnbc.com/2023/07/24/jj-to-reduce-kenvue-stake-by-80percent-through-stock-exchange-offer.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T09:03:42-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 10:37:16",
    "publisher": "The Motley Fool",
    "title": "3 Ultrareliable Dividend Stocks to Buy and Hold for Decades",
    "image": "https://images.financialmodelingprep.com/news/3-ultrareliable-dividend-stocks-to-buy-and-hold-for-20230724.jpg",
    "site": "fool.com",
    "text": "Now that Johnson & Johnson no longer sells consumer goods, it's poised to grow, along with sales of pharmaceuticals and medical technology. Medtronic's dominance in the medical device industry has allowed it to raise its dividend payout for 46 consecutive years.",
    "url": "https://www.fool.com/investing/2023/07/24/3-ultra-reliable-dividend-stocks-buy-and-hold-for/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T10:37:16-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 11:30:34",
    "publisher": "Investopedia",
    "title": "Johnson & Johnson Offers Exchange for Shares of Spinoff Kenvue",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-offers-exchange-for-shares-of-spinoff-kenvue-20230724.jpg",
    "site": "investopedia.com",
    "text": "Johnson & Johnson offers its shareholders the choice to exchange its shares for Kenvue's, the consumer health company it spun off just two months ago.",
    "url": "https://www.investopedia.com/johnson-and-johnson-offers-exchange-for-shares-of-spinoff-kenvue-7564508",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T11:30:34-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 13:05:35",
    "publisher": "Zacks Investment Research",
    "title": "Are You Looking for a High-Growth Dividend Stock?",
    "image": "https://images.financialmodelingprep.com/news/are-you-looking-for-a-highgrowth-dividend-stock-20230724.jpg",
    "site": "zacks.com",
    "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?",
    "url": "https://www.zacks.com/stock/news/2126275/are-you-looking-for-a-high-growth-dividend-stock",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T13:05:35-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 13:50:10",
    "publisher": "Zacks Investment Research",
    "title": "3 Reasons Why Growth Investors Shouldn't Overlook Johnson & Johnson (JNJ)",
    "image": "https://images.financialmodelingprep.com/news/3-reasons-why-growth-investors-shouldnt-overlook-johnson-johnson-20230724.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) possesses solid growth attributes, which could help it handily outperform the market.",
    "url": "https://www.zacks.com/stock/news/2126372/3-reasons-why-growth-investors-shouldn-t-overlook-johnson-johnson-jnj",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T13:50:10-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 14:50:46",
    "publisher": "GuruFocus",
    "title": "From Snowball to Avalanche: Understanding Buffett's Approach to Compound Interest",
    "image": "https://images.financialmodelingprep.com/news/from-snowball-to-avalanche-understanding-buffetts-approach-to-compound-20230724.jpg",
    "site": "gurufocus.com",
    "text": "\"Compound interest is like being at the top of a very large hill with wet snow and starting with a snowball and getting it rolling downhill,\" Warren Buffett (Trades, Portfolio) once said at a Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) shareholder meeting. He attributed the metaphor to Charlie Munger (Trades, Portfolio), but it aptly describes the power of compounding returns – a fundamental principle that has guided his investment strategy from the beginning.",
    "url": "https://www.gurufocus.com/news/2046587/from-snowball-to-avalanche-understanding-buffetts-approach-to-compound-interest",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T14:50:46-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-24 17:25:34",
    "publisher": "Investopedia",
    "title": "S&P 500 Gains and Losses Today: Oil Industry Stocks Surge as Oil Prices Rise",
    "image": "https://images.financialmodelingprep.com/news/sp-500-gains-and-losses-today-oil-industry-stocks-20230724.png",
    "site": "investopedia.com",
    "text": "U.S. equities gained after better-than-expected second quarter earnings reports, with the S&P 500 rising 0.4% on Monday, July 24, 2023.",
    "url": "https://www.investopedia.com/s-and-p-500-gains-and-losses-today-oil-industry-stocks-surge-as-oil-prices-rise-7564889",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-24T17:25:34-04:00",
    "date_et": "2023-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 07:30:00",
    "publisher": "The Motley Fool",
    "title": "Dividend Investors in This Unique Stock-Split Stock Have a Decision to Make",
    "image": "https://images.financialmodelingprep.com/news/dividend-investors-in-this-unique-stocksplit-stock-have-a-20230725.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson is splitting off its consumer healthcare business to shareholders. They can exchange all, some, or none of their shares for Kenvue stock.",
    "url": "https://www.fool.com/investing/2023/07/25/dividend-investors-in-this-unique-stock-split-stoc/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T07:30:00-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 08:25:00",
    "publisher": "The Motley Fool",
    "title": "3 Stocks You Can Keep Forever",
    "image": "https://images.financialmodelingprep.com/news/3-stocks-you-can-keep-forever-20230725.jpg",
    "site": "fool.com",
    "text": "Lowe's has shown a triple-digit total price and EPS growth over the past decade. Johnson & Johnson and Parker Hannifin are Dividend Kings.",
    "url": "https://www.fool.com/investing/2023/07/25/3-stocks-you-can-keep-forever/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T08:25:00-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 09:37:00",
    "publisher": "The Motley Fool",
    "title": "Is Johnson & Johnson Stock a Buy Now?",
    "image": "https://images.financialmodelingprep.com/news/is-johnson-johnson-stock-a-buy-now-20230725.jpg",
    "site": "fool.com",
    "text": "Shares of Johnson & Johnson marched higher after the company reported second-quarter earnings last week. In addition to results that beat Wall Street's expectations, Johnson & Johnson raised its earnings outlook.",
    "url": "https://www.fool.com/investing/2023/07/25/is-johnson-johnson-stock-a-buy-now/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T09:37:00-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 10:07:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Dividend Stocks to Buy and Hold Forever",
    "image": "https://images.financialmodelingprep.com/news/2-top-dividend-stocks-to-buy-and-hold-forever-20230725.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson and Abbott Laboratories are Dividend Kings -- a boon for income investors. J&J's strength in pharma and medical devices should allow it to perform well despite legal troubles.",
    "url": "https://www.fool.com/investing/2023/07/25/2-top-dividend-stocks-to-buy-and-hold-forever/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T10:07:00-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 10:07:14",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-is-a-trending-stock-facts-to-20230725.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://www.zacks.com/stock/news/2126789/johnson-johnson-jnj-is-a-trending-stock-facts-to-know-before-betting-on-it",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T10:07:14-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-25 15:23:03",
    "publisher": "Zacks Investment Research",
    "title": "4 Stocks to Buy Following Beat-and-Raise Quarters",
    "image": "https://images.financialmodelingprep.com/news/4-stocks-to-buy-following-beatandraise-quarters-20230725.jpg",
    "site": "zacks.com",
    "text": "Earnings season continues to chug along, with big tech stealing the spotlight this week. We've received many positive surprises throughout the period as companies navigate a unique macroeconomic situation.",
    "url": "https://www.zacks.com/commentary/2127252/4-stocks-to-buy-following-beat-and-raise-quarters",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-25T15:23:03-04:00",
    "date_et": "2023-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 06:00:00",
    "publisher": "The Motley Fool",
    "title": "J&J's Medtech Business Is Soaring. Time to Buy the Stock?",
    "image": "https://images.financialmodelingprep.com/news/jjs-medtech-business-is-soaring-time-to-buy-the-20230726.jpg",
    "site": "fool.com",
    "text": "J&J is moving toward its goal of becoming a two-unit company, focused on pharmaceuticals and medtech. It's in the process of spinning off its consumer products business.",
    "url": "https://www.fool.com/investing/2023/07/26/jjs-medtech-business-is-soaring-time-to-buy-the-st/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T06:00:00-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 08:30:00",
    "publisher": "The Motley Fool",
    "title": "3 No-Brainer Warren Buffett Stocks to Buy Right Now",
    "image": "https://images.financialmodelingprep.com/news/3-nobrainer-warren-buffett-stocks-to-buy-right-now-20230726.jpg",
    "site": "fool.com",
    "text": "Bank of America is seeing the benefit from rising interest rates. Apple is one of the most shareholder-friendly companies on the public markets.",
    "url": "https://www.fool.com/investing/2023/07/26/3-no-brainer-warren-buffett-stocks-to-buy-right-no/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T08:30:00-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 10:10:00",
    "publisher": "The Motley Fool",
    "title": "Like Growing Dividend Income? Buy This Dividend King",
    "image": "https://images.financialmodelingprep.com/news/like-growing-dividend-income-buy-this-dividend-king-20230726.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson's sales and profits rose in the second quarter. The drugmaker's dividend is safe and almost double that of the S&P 500 index to boot.",
    "url": "https://www.fool.com/investing/2023/07/26/like-growing-dividend-income-buy-this-dividend-kin/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T10:10:00-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 10:55:36",
    "publisher": "Zacks Investment Research",
    "title": "Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-jnj-is-a-top-value-stock-20230726.jpg",
    "site": "zacks.com",
    "text": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://www.zacks.com/stock/news/2127737/why-johnson-johnson-jnj-is-a-top-value-stock-for-the-long-term",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T10:55:36-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 22:03:49",
    "publisher": "Seeking Alpha",
    "title": "Building The Dividend Growth Portfolio In 2023",
    "image": "https://images.financialmodelingprep.com/news/building-the-dividend-growth-portfolio-in-2023-20230726.jpg",
    "site": "seekingalpha.com",
    "text": "My U.S. dividend growth portfolio, constructed in 2015, has outperformed the market by over 2% annually. The portfolio was designed to be resilient in a major stock market correction, focusing on dividend achievers with at least 10 years of dividend growth. For building a similar portfolio in 2023, I considered valuation and growth, leaning towards larger cap or mega-cap stocks, and factored in retirement income needs.",
    "url": "https://seekingalpha.com/article/4620261-building-dividend-growth-portfolio-2023",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T22:03:49-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-26 23:35:45",
    "publisher": "InvestorPlace",
    "title": "‘Set It and Forget It' With These 3 Stocks to Buy",
    "image": "https://images.financialmodelingprep.com/news/set-it-and-forget-it-with-these-3-stocks-20230726.jpg",
    "site": "investorplace.com",
    "text": "Investing can be complicated. That's especially true when putting money to work in fast-moving industries with rapidly changing product cycles.",
    "url": "https://investorplace.com/2023/07/set-it-and-forget-it-with-these-3-stocks-to-buy/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-26T23:35:45-04:00",
    "date_et": "2023-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 05:30:00",
    "publisher": "The Motley Fool",
    "title": "Better Medtech Buy: J&J vs. Medtronic",
    "image": "https://images.financialmodelingprep.com/news/better-medtech-buy-jj-vs-medtronic-20230727.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson and Medtronic are leaders in the medical device industry and both delivered growth in the most recent quarter. One of these stocks looks like a better buy right now.",
    "url": "https://www.fool.com/investing/2023/07/27/better-medtech-buy-jj-vs-medtronic/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T05:30:00-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 08:50:49",
    "publisher": "Seeking Alpha",
    "title": "A Historic Opportunity To Win Big With Dividend Stocks",
    "image": "https://images.financialmodelingprep.com/news/a-historic-opportunity-to-win-big-with-dividend-stocks-20230727.jpg",
    "site": "seekingalpha.com",
    "text": "Dividend stocks are today offering a historic opportunity. Share prices are down and dividend yields are now materially higher. We show the huge difference that it can make over the long run.",
    "url": "https://seekingalpha.com/article/4620411-a-historic-opportunity-to-win-big-with-dividend-stocks",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T08:50:49-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 09:27:21",
    "publisher": "Zacks Investment Research",
    "title": "3 Top Blue Chip Stocks to Ride the Dow Rally",
    "image": "https://images.financialmodelingprep.com/news/3-top-blue-chip-stocks-to-ride-the-dow-20230727.jpg",
    "site": "zacks.com",
    "text": "As the Dow continues to scale upward, it's prudent to invest in stocks such as JPMorgan (JPM), Walmart (WMT) and Johnson & Johnson (JNJ) that are listed on the said index and are financially sound.",
    "url": "https://www.zacks.com/stock/news/2128715/3-top-blue-chip-stocks-to-ride-the-dow-rally",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T09:27:21-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 09:27:55",
    "publisher": "Zacks Investment Research",
    "title": "Dow Jones ETFs Continue Winning Run as Rates at 2001 High",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-etfs-continue-winning-run-as-rates-at-20230727.jpg",
    "site": "zacks.com",
    "text": "Fed raised its benchmark interest rate by 0.25% on Wednesday, leaving room for more hikes this year. Such rising rate environment is a plus for the Dow Jones ETFs.",
    "url": "https://www.zacks.com/stock/news/2128598/dow-jones-etfs-continue-winning-run-as-rates-at-2001-high",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T09:27:55-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 09:40:14",
    "publisher": "The Motley Fool",
    "title": "AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry",
    "image": "https://images.financialmodelingprep.com/news/ai-stocks-are-overpriced-the-next-big-growth-opportunity-20230727.jpg",
    "site": "fool.com",
    "text": "Artificial intelligence stocks have been soaring this year, but they're valued extremely expensively now. Recent earnings reports suggest the healthcare industry is experiencing strong growth.",
    "url": "https://www.fool.com/investing/2023/07/27/ai-stocks-overpriced-next-big-growth-opportunity/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T09:40:14-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 09:42:27",
    "publisher": "InvestorPlace",
    "title": "7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes",
    "image": "https://images.financialmodelingprep.com/news/7-millionairemaker-healthcare-stocks-to-buy-before-the-window-20230727.jpg",
    "site": "investorplace.com",
    "text": "Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.",
    "url": "https://investorplace.com/2023/07/7-millionaire-maker-healthcare-stocks-to-buy-before-the-window-closes/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T09:42:27-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-27 10:13:06",
    "publisher": "Zacks Investment Research",
    "title": "Fed's July Rate Hike and Comments Match Expectations: 5 Picks",
    "image": "https://images.financialmodelingprep.com/news/feds-july-rate-hike-and-comments-match-expectations-5-20230727.jpg",
    "site": "zacks.com",
    "text": "We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.",
    "url": "https://www.zacks.com/stock/news/2128716/fed-s-july-rate-hike-and-comments-match-expectations-5-picks",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-27T10:13:06-04:00",
    "date_et": "2023-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 05:15:20",
    "publisher": "InvestorPlace",
    "title": "The 3 Best Blue-Chip Dividend Stocks to Buy for July",
    "image": "https://images.financialmodelingprep.com/news/the-3-best-bluechip-dividend-stocks-to-buy-for-20230728.jpg",
    "site": "investorplace.com",
    "text": "Blue-chip dividend stocks are a great addition to an investors portfolio because they offer both secure dividends and strong growth potential. In this article I will take a look at three of the best ones to get in on before the end of July.",
    "url": "https://investorplace.com/2023/07/the-3-best-blue-chip-dividend-stocks-to-buy-for-july/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T05:15:20-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 07:21:00",
    "publisher": "The Motley Fool",
    "title": "Got $2,500? 2 Top Stocks You Can Buy and Hold for a Lifetime",
    "image": "https://images.financialmodelingprep.com/news/got-2500-2-top-stocks-you-can-buy-and-20230728.jpg",
    "site": "fool.com",
    "text": "Buying and holding stocks for decades, even a lifetime, is one of the best ways to build wealth. Companies with big growth catalysts, defined goals, and focus on shareholder returns are great contenders.",
    "url": "https://www.fool.com/investing/2023/07/28/got-2500-2-top-stocks-to-buy-and-hold-for-lifetime/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T07:21:00-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 08:37:00",
    "publisher": "The Motley Fool",
    "title": "3 Things About Johnson & Johnson Every Smart Investor Knows",
    "image": "https://images.financialmodelingprep.com/news/3-things-about-johnson-johnson-every-smart-investor-knows-20230728.jpg",
    "site": "fool.com",
    "text": "Johnson & Johnson is separating itself from Kenvue, the company formed from the spinoff of its former Consumer Healthcare segment. The company's record of innovation is paying off.",
    "url": "https://www.fool.com/investing/2023/07/28/3-things-about-johnson-johnson-every-smart-investo/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T08:37:00-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 11:29:39",
    "publisher": "GuruFocus",
    "title": "How Productive Assets Outshine Gold in Buffett's Investment Philosophy",
    "image": "https://images.financialmodelingprep.com/news/how-productive-assets-outshine-gold-in-buffetts-investment-philosophy-20230728.jpg",
    "site": "gurufocus.com",
    "text": "Warren Buffett (Trades, Portfolio), the CEO of Berkshire Hathaway Inc. ( BRK.A , Financial) ( BRK.B , Financial), has often been asked for his opinion on gold as an investment vehicle, and, to many people's surprise, he is not in favor. Far from it.",
    "url": "https://www.gurufocus.com/news/2051312/how-productive-assets-outshine-gold-in-buffetts-investment-philosophy",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T11:29:39-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 16:41:30",
    "publisher": "Reuters",
    "title": "J&J effort to resolve talc lawsuits in bankruptcy fails a second time",
    "image": "https://images.financialmodelingprep.com/news/jj-effort-to-resolve-talc-lawsuits-in-bankruptcy-fails-20230728.jpg",
    "site": "reuters.com",
    "text": "A U.S. judge on Friday shot down Johnson & Johnson's second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.",
    "url": "https://www.reuters.com/legal/jj-effort-resolve-talc-lawsuits-bankruptcy-fails-second-time-2023-07-28/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T16:41:30-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 17:26:00",
    "publisher": "CNBC",
    "title": "Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-effort-to-resolve-talc-cancer-lawsuits-in-20230728.jpeg",
    "site": "cnbc.com",
    "text": "The decision jeopardizes J&J's proposed $8.9 billion settlement that would stop new lawsuits over its talc baby powder and other products from being filed.",
    "url": "https://www.cnbc.com/2023/07/28/jj-effort-to-resolve-talc-cancer-lawsuits-fails-a-second-time-.html",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T17:26:00-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-28 18:25:00",
    "publisher": "Business Wire",
    "title": "Dismissal of LTL Bankruptcy Signals Latest Failure by J&J to Evade Responsibility for Decades of Deceit in Talc-Asbestos Litigation",
    "image": "https://images.financialmodelingprep.com/news/dismissal-of-ltl-bankruptcy-signals-latest-failure-by-jj-20230728.jpg",
    "site": "businesswire.com",
    "text": "TRENTON, N.J.--(BUSINESS WIRE)--The dismissal of the second attempt by Johnson & Johnson's LTL subsidiary to assert bankruptcy protection and limit corporate liability for manufacturing and marketing asbestos-laden talcum powder products should lead to the rescheduling of trials in federal and state civil courts, say lawyers representing thousands of ovarian cancer and mesothelioma victims. “Today the court has finally, rightfully denied this latest attempt by one of the world's largest and.",
    "url": "https://www.businesswire.com/news/home/20230728693741/en/Dismissal-of-LTL-Bankruptcy-Signals-Latest-Failure-by-JJ-to-Evade-Responsibility-for-Decades-of-Deceit-in-Talc-Asbestos-Litigation/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-28T18:25:00-04:00",
    "date_et": "2023-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-30 05:21:00",
    "publisher": "The Motley Fool",
    "title": "Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings",
    "image": "https://images.financialmodelingprep.com/news/want-500-in-super-safe-annual-dividend-income-invest-20230730.jpg",
    "site": "fool.com",
    "text": "Income stocks have meaningfully outperformed publicly traded companies that don't pay a dividend over extended timelines. Dividend Kings -- companies that have raised their base annual payout for at least 50 consecutive years -- are in a class of their own.",
    "url": "https://www.fool.com/investing/2023/07/30/want-500-safe-annual-dividend-income-invest-9900/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-30T05:21:00-04:00",
    "date_et": "2023-07-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-30 06:04:00",
    "publisher": "The Motley Fool",
    "title": "These 3 Dow Stocks Are Set to Soar in 2023 and Beyond",
    "image": "https://images.financialmodelingprep.com/news/these-3-dow-stocks-are-set-to-soar-in-20230730.jpg",
    "site": "fool.com",
    "text": "The Dow Jones Industrial Average comprises of 30 large, established, and profitable companies. While each of these blue-chip companies are great in their own right, three Dow stocks have huge potential in the near future.",
    "url": "https://www.fool.com/investing/2023/07/30/these-3-dow-stocks-are-set-to-soar-in-2023-beyond/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-30T06:04:00-04:00",
    "date_et": "2023-07-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 08:05:39",
    "publisher": "Investopedia",
    "title": "5 Things to Know Before Markets Open",
    "image": "https://images.financialmodelingprep.com/news/5-things-to-know-before-markets-open-20230731.jpg",
    "site": "investopedia.com",
    "text": "Shares of SoFi Networks surged ahead of its earnings report and trucking company Yellow shut down operations as it prepares for bankruptcy. Here's what investors need to know today.",
    "url": "https://www.investopedia.com/5-things-to-know-before-markets-open-july-31-2023-7567494",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T08:05:39-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 09:38:16",
    "publisher": "Zacks Investment Research",
    "title": "Forget Soft Landing for Economy, Think About a New Takeoff",
    "image": "https://images.financialmodelingprep.com/news/forget-soft-landing-for-economy-think-about-a-new-20230731.jpg",
    "site": "zacks.com",
    "text": "At this stage, we have narrowed our search to five stocks. These are: META, GOOGL, KO, PEP, JNJ.",
    "url": "https://www.zacks.com/stock/news/2129842/forget-soft-landing-for-economy-think-about-a-new-takeoff",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T09:38:16-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 11:19:08",
    "publisher": "The Motley Fool",
    "title": "Why Johnson & Johnson Stock Is Sinking Today",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-stock-is-sinking-today-20230731.jpg",
    "site": "fool.com",
    "text": "A U.S. court dismissed the second bankruptcy filing of a J&J subsidiary. Johnson & Johnson had hoped to put its talc litigation to bed but can't do so yet.",
    "url": "https://www.fool.com/investing/2023/07/31/why-johnson-johnson-stock-is-sinking-today/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T11:19:08-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 11:51:11",
    "publisher": "Proactive Investors",
    "title": "J&J's second attempt to skirt to talc cancer lawsuits with bankruptcy claim rejected by judge",
    "image": "https://images.financialmodelingprep.com/news/jjs-second-attempt-to-skirt-to-talc-cancer-lawsuits-20230731.jpg",
    "site": "proactiveinvestors.com",
    "text": "For the second time, Johnson & Johnson (NYSE:JNJ) has seen its attempt to resolve an avalanche of lawsuits that its talc baby powder and other talc-based products caused cancer rebuffed in bankruptcy court.  A federal bankruptcy judge in New Jersey ruled that the second bankruptcy filing from J&J subsidiary LTL Management must be dismissed, saying the company was not in imminent financial distress.",
    "url": "https://www.proactiveinvestors.com/companies/news/1022189?SNAPI",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T11:51:11-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 13:10:37",
    "publisher": "Investopedia",
    "title": "Markets Rise at Midday, on Track for a Monthly Gain on Profits, Lower Inflation",
    "image": "https://images.financialmodelingprep.com/news/markets-rise-at-midday-on-track-for-a-monthly-20230731.jpg",
    "site": "investopedia.com",
    "text": "U.S. equities advanced at midday on Monday, July 31, 2023, heading for a winning month on strong earnings and easing inflation.",
    "url": "https://www.investopedia.com/markets-rose-at-midday-and-headed-for-a-monthly-gain-on-profits-lower-inflation-7567613",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T13:10:37-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 14:30:00",
    "publisher": "Barrons",
    "title": "J&J Just Can't Seem to Solve Its Talc Problem. The Latest Setback.",
    "image": "https://images.financialmodelingprep.com/news/jj-just-cant-seem-to-solve-its-talc-problem-20230731.jpg",
    "site": "barrons.com",
    "text": "The Monday selloff in Johnson & Johnson stock appears to have been sparked by an unfavorable ruling by a bankruptcy judge in New Jersey.",
    "url": "https://www.barrons.com/articles/j-j-stock-talc-lawsuit-setback-1c6f37a4",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T14:30:00-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 15:07:00",
    "publisher": "Business Wire",
    "title": "Nachawati Law Group Trial Lawyers Renew Commitment to Cancer Victims After Judge's Rejection of Johnson & Johnson's Proposed $8.9B Settlement",
    "image": "https://images.financialmodelingprep.com/news/nachawati-law-group-trial-lawyers-renew-commitment-to-cancer-20230731.jpg",
    "site": "businesswire.com",
    "text": "TRENTON, N.J.--(BUSINESS WIRE)--Nachawati Law Group vowed to press on with lawsuits against Johnson & Johnson after the dismissal of a proposed settlement of talc-cancer claims.",
    "url": "https://www.businesswire.com/news/home/20230731780194/en/Nachawati-Law-Group-Trial-Lawyers-Renew-Commitment-to-Cancer-Victims-After-Judge%E2%80%99s-Rejection-of-Johnson-Johnson%E2%80%99s-Proposed-8.9B-Settlement/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T15:07:00-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 15:30:20",
    "publisher": "Reuters",
    "title": "J&J shares on track for biggest daily drop in 3 years on talc setback",
    "image": "https://images.financialmodelingprep.com/news/jj-shares-on-track-for-biggest-daily-drop-in-20230731.jpg",
    "site": "reuters.com",
    "text": "Shares in Johnson & Johnson were down 4.1% on Monday and looked set for their biggest one-day percentage loss since June 2020 after a U.S. judge shot down its second attempt to resolve tens of thousands of talc-related lawsuits.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/jj-shares-track-biggest-daily-drop-3-years-talc-setback-2023-07-31/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T15:30:20-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 15:52:35",
    "publisher": "InvestorPlace",
    "title": "7 Stocks to Buy Before They Surpass 2021 Highs",
    "image": "https://images.financialmodelingprep.com/news/7-stocks-to-buy-before-they-surpass-2021-highs-20230731.jpg",
    "site": "investorplace.com",
    "text": "The stock market has rebounded in 2023 following a year marked by rate hikes that pulled everything much lower. Leading indexes fell dramatically with the S&P 500 shedding 18.25% of its value.",
    "url": "https://investorplace.com/2023/07/7-stocks-to-buy-before-they-surpass-2021-highs-stocks-to-watch-before-new-peaks/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T15:52:35-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 16:35:36",
    "publisher": "Investopedia",
    "title": "J&J Leads Losses on the Dow After Court Rejects Bankruptcy Plans",
    "image": "https://images.financialmodelingprep.com/news/jj-leads-losses-on-the-dow-after-court-rejects-bankruptcy-20230731.jpg",
    "site": "investopedia.com",
    "text": "Johnson & Johnson shares dropped after a judge ruled against its plan to resolve talcum powder-related lawsuits.",
    "url": "https://www.investopedia.com/jandj-plan-to-resolve-talc-related-lawsuits-rejected-7567772",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T16:35:36-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 17:10:35",
    "publisher": "Investopedia",
    "title": "Dow Jones Today: Index Higher For Second Straight Month",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-today-index-higher-for-second-straight-month-20230731.jpg",
    "site": "investopedia.com",
    "text": "The Dow closed July with a gain of 3%, moving up 100 points, or 0.28% on the session, as investors watch earnings and prepare for Friday's job report.",
    "url": "https://www.investopedia.com/dow-jones-today-index-higher-for-second-straight-month-7567900",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T17:10:35-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-07-31 18:15:34",
    "publisher": "Investopedia",
    "title": "S&P 500 Gains and Losses Today: Oil Industry Stocks Advance as Oil Prices Climb",
    "image": "https://images.financialmodelingprep.com/news/sp-500-gains-and-losses-today-oil-industry-stocks-20230731.png",
    "site": "investopedia.com",
    "text": "The S&P 500 was little changed to start the week on Monday, July 31, 2023, edging 0.2% higher as oil stocks gained on the back of higher oil prices.",
    "url": "https://www.investopedia.com/s-and-p-500-gains-and-losses-today-stocks-higher-on-china-optimism-7567860",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-07-31T18:15:34-04:00",
    "date_et": "2023-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-01 11:45:48",
    "publisher": "InvestorPlace",
    "title": "3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now",
    "image": "https://images.financialmodelingprep.com/news/3-cheap-healthcare-stocks-that-smart-investors-will-snap-20230801.jpg",
    "site": "investorplace.com",
    "text": "Healthcare has been a laggard this year. A slowpoke, a dawdler, an idler.",
    "url": "https://investorplace.com/2023/08/healthcare-stocks-to-buy-2/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-01T11:45:48-04:00",
    "date_et": "2023-08-01"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-02 04:05:54",
    "publisher": "Seeking Alpha",
    "title": "Time To Go Defensive With These ETFs",
    "image": "https://images.financialmodelingprep.com/news/time-to-go-defensive-with-these-etfs-20230802.jpg",
    "site": "seekingalpha.com",
    "text": "High-beta stocks have outperformed defensive stocks in the stock market recently, raising questions about the effectiveness of low-volatility and dividend growth investing. ROBECO's research shows that low-volatility investing can significantly improve long-term performance, particularly in market environments with increased retail investor participation. Low-risk ETFs, such as healthcare names and dividend aristocrats, offer exposure to fundamentally strong factors and tend to perform well during periods of stagflation, high inflation, and decent economic growth.",
    "url": "https://seekingalpha.com/article/4622567-time-go-defensive-with-these-etfs",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-02T04:05:54-04:00",
    "date_et": "2023-08-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-02 09:47:57",
    "publisher": "InvestorPlace",
    "title": "3 Consumer Staples Stocks to Dump ASAP",
    "image": "https://images.financialmodelingprep.com/news/3-consumer-staples-stocks-to-dump-asap-20230802.png",
    "site": "investorplace.com",
    "text": "Investing in companies that make products people buy day-in and day-out is a smart way to weather an economic storm, but there are some consumer staples stocks to sell which are the exception to that rule. A consumer staples stock includes a whole range of companies— from over-the-counter medicines to household products, food and even alcohol and tobacco.",
    "url": "https://investorplace.com/2023/08/3-consumer-staples-stocks-to-dump-asap/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-02T09:47:57-04:00",
    "date_et": "2023-08-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-02 15:11:00",
    "publisher": "Reuters",
    "title": "J&J talc cancer plaintiffs want 6-month ban on further bankruptcy filings",
    "image": "https://images.financialmodelingprep.com/news/jj-talc-cancer-plaintiffs-want-6month-ban-on-further-20230802.jpg",
    "site": "reuters.com",
    "text": "Lawyers for thousands of people who claim Johnson & Johnson's talc-based powders caused them to develop cancer on Wednesday urged a U.S. judge to temporarily block the company from seeking bankruptcy protection for a third time for its talc subsidiary.",
    "url": "https://www.reuters.com/legal/jj-talc-cancer-plaintiffs-want-6-month-ban-further-bankruptcy-filings-2023-08-02/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-02T15:11:00-04:00",
    "date_et": "2023-08-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-02 16:55:48",
    "publisher": "Investopedia",
    "title": "Dow Jones Today: Index Dives on Rating Cut",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-today-index-dives-on-rating-cut-20230802.jpg",
    "site": "investopedia.com",
    "text": "Investors reacted to the Fitch Rating agency's downgrade of U.S. credit, sending long-term bonds higher and the Dow Jones lower by about 1%, or 350 points.",
    "url": "https://www.investopedia.com/dow-jones-today-index-dives-on-rating-cut-7569021",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-02T16:55:48-04:00",
    "date_et": "2023-08-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-03 06:00:39",
    "publisher": "InvestorPlace",
    "title": "Sell Alert: 3 Healthcare Stocks to Dump ASAP",
    "image": "https://images.financialmodelingprep.com/news/sell-alert-3-healthcare-stocks-to-dump-asap-20230803.jpg",
    "site": "investorplace.com",
    "text": "Healthcare stocks are generally thought of as safe or even recession-proof investments. This is because the underlying companies provide essential products and services that are required no matter what the broader economy is doing.",
    "url": "https://investorplace.com/2023/08/sell-alert-3-healthcare-stocks-to-dump-asap/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-03T06:00:39-04:00",
    "date_et": "2023-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-03 09:24:55",
    "publisher": "InvestorPlace",
    "title": "Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights",
    "image": "https://images.financialmodelingprep.com/news/buckle-up-3-healthcare-stocks-set-to-soar-to-20230803.jpg",
    "site": "investorplace.com",
    "text": "Everyone seems to be focused on the Nasdaq, as tech stocks lead the way higher. While that may be the case, we've seen soaring healthcare stocks too.",
    "url": "https://investorplace.com/2023/08/buckle-up-3-healthcare-stocks-set-to-soar-to-new-heights/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-03T09:24:55-04:00",
    "date_et": "2023-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-03 15:00:45",
    "publisher": "Zacks Investment Research",
    "title": "Looking to Bet On Perfect AAA Credit Ratings? Play These ETFs",
    "image": "https://images.financialmodelingprep.com/news/looking-to-bet-on-perfect-aaa-credit-ratings-play-20230803.jpg",
    "site": "zacks.com",
    "text": "In light of Fitch Ratings' downgrade of U.S. credit, investors might be interested in identifying companies and countries that still hold the desirable 'AAA' credit rating.",
    "url": "https://www.zacks.com/stock/news/2132188/looking-to-bet-on-perfect-aaa-credit-ratings-play-these-etfs",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-03T15:00:45-04:00",
    "date_et": "2023-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2023-08-03 19:24:57",
    "publisher": "InvestorPlace",
    "title": "Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.",
    "image": "https://images.financialmodelingprep.com/news/buckle-up-3-bluechip-stocks-set-to-soar-to-20230803.jpg",
    "site": "investorplace.com",
    "text": "The U.S. stock market has been roaring higher lately, even though it has started off August on a tough note. While the S&P 500 has fallen about 2% so far this month, it's been on a strong run otherwise.",
    "url": "https://investorplace.com/2023/08/buckle-up-3-blue-chip-stocks-set-to-soar-to-new-heights/",
    "ticker": "JNJ",
    "event_date": "2023-07-20",
    "window_start": "2023-07-06",
    "window_end": "2023-08-03",
    "publishedDateET": "2023-08-03T19:24:57-04:00",
    "date_et": "2023-08-03"
  }
]